Literature DB >> 9441785

Life-threatening myelosuppression in patients with occult renal impairment receiving topotecan.

S O'Reilly, D K Armstrong, L B Grochow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9441785     DOI： 10.1006/gyno.1997.4896

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  6 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Topotecan: a review of its efficacy in small cell lung cancer.

Authors:  D Ormrod; C M Spencer
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

3.  Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors.

Authors:  Fei Tang; Eleftheria Tsakalozou; Susanne M Arnold; Chee M Ng; Markos Leggas
Journal:  Invest New Drugs       Date:  2019-02-28       Impact factor: 3.850

Review 4.  Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

Authors:  J Andrew Skirvin; Stuart M Lichtman
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 5.  Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy.

Authors:  Stuart M Lichtman; Manpreet K Boparai
Journal:  Curr Treat Options Oncol       Date:  2008-07-29

Review 6.  Pharmacological factors influencing anticancer drug selection in the elderly.

Authors:  Veena John; Sandeep Mashru; Stuart Lichtman
Journal:  Drugs Aging       Date:  2003       Impact factor: 4.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.